A solid dispersion transdermal drug delivery system comprising a therapeuticagent in a stable amorphous formand a combination polymeric stabilizing and dispersing agent having a hydrogenbond-forming functional group, and a method ofmanufacturing these systems is provided. The weight ratio of the combinationpolymeric stabilizing and dispersing agent to thetherapeutic agent is also disclosed.